ProCE Banner Activity

Expert Guidance on the Evolving Therapeutic Landscape for HER2-Positive Early-Stage Breast Cancer: Slides

Slideset

Download these expert-selected slides on optimal treatment for patients with HER2-positive early breast cancer.

Released: February 02, 2021

Expiration: February 01, 2022

Share

Faculty

Jame Abraham

Jame Abraham, MD, FACP

Enterprise Chair and Professor of Medicine
Department of Hematology and Medical Oncology
Cleveland Clinic
Cleveland, Ohio

Provided by

Provided by the National Comprehensive Cancer Network in collaboration with Clinical Care Options, LLC

ProCE Banner

Supporters

Supported by educational grants from

Genentech, a member of the Roche Group

Puma Biotechnology, Inc.

Faculty Disclosure

Primary Author

Jame Abraham, MD, FACP

Enterprise Chair and Professor of Medicine
Department of Hematology and Medical Oncology
Cleveland Clinic
Cleveland, Ohio

Jame Abraham, MD, FACP, has no relevant financial relationships to disclose.